Catafau, Ana M <br/><br/>
Contribution of SPECT measurements of D2 and 5-HT2A occupancy to the clinical development of the antipsychotic SB-773812.  [electronic resource] 

 -  Journal of nuclear medicine : official publication, Society of Nuclear Medicine  Apr 2011 
 - 526-34 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1535-5667 
<br/><br/><label>Standard No.: </label>10.2967/jnumed.110.081885  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Algorithms<br/>Antipsychotic Agents--pharmacokinetics<br/>Brain--diagnostic imaging<br/>Cohort Studies<br/>Diagnostic and Statistical Manual of Mental Disorders<br/>Dose-Response Relationship, Drug<br/>Humans<br/>Image Processing, Computer-Assisted<br/>Iodobenzenes<br/>Male<br/>Piperidines<br/>Radiopharmaceuticals<br/>Receptor, Serotonin, 5-HT2A--metabolism<br/>Receptors, Dopamine D2--metabolism<br/>Risperidone--pharmacokinetics<br/>Schizophrenia--metabolism<br/>Tomography, Emission-Computed, Single-Photon--methods<br/>Young Adult